Drug Shortage Report for PDP-LEVETIRACETAM
| Report ID | 125104 |
| Drug Identification Number | 02490447 |
| Brand name | PDP-LEVETIRACETAM |
| Common or Proper name | LEVETIRACETAM |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVETIRACETAM |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
| Packaging size | 300mL |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-09-09 |
| Estimated end date | 2020-10-09 |
| Actual end date | 2020-10-05 |
| Shortage status | Resolved |
| Updated date | 2020-10-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-10-06 | English | Compare |
| v4 | 2020-10-05 | French | Compare |
| v3 | 2020-10-05 | English | Compare |
| v2 | 2020-09-25 | French | Compare |
| v1 | 2020-09-25 | English | Compare |
Showing 1 to 5 of 5